Between February 2024 and October 2025, the number of American adults who reported taking GLP-1s for weight loss more than doubled, constituting roughly 12% of the population, according to Gallup polling
By combining these three mechanisms into a single, weekly injection, Retatrutide is being studied for its potential to address the biological set point that often keeps people stuck at a higher weight
If you have additional questions, please contact our Provider Services Helpline at 1-888-991-9023
Senior management, together with the board of directors, are actively focused on preserving capital and will initiate a strategic process to explore and review a range of strategic options focused on maximizing shareholder value, Essa Chairman Richard Glickman stated
They are mostly in development or limited-release trials
Ive lost weight and improved my health on Ozempic and Wegovy